Status:

ACTIVE_NOT_RECRUITING

Digital Treatment of Irritable Bowel Syndrome (IBS)

Lead Sponsor:

Haukeland University Hospital

Conditions:

IBS - Irritable Bowel Syndrome

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

The aim of this work is to identify whether the digital treatment program Mage-tarmskolen has an effect on patients with IBS. Our secondary objectives is to address multiple aspects of digital treatmt...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • \- Diagnosed with IBS in the primary or secondary healthcare service.
  • Patients aged 18-70 years with IBS defined by the Rome IV criteria: Recurrent abdominal pain, on average at least 1 day per week during the previous 3 months, that is associated with two or more of the following: i) Defecation, either increased pain or pain relief, ii) Change in stool frequency, iii) Change in stool form (appearance)
  • All participants \>50 years: Colonoscopy within the last 5 years prior to study entry excluding other pathology
  • Bank-ID and access to tablet, PC or smart phone.
  • No known presence of: symptomatic endometriosis, Diabetes type 1 and 2, Malignant disease (excluding basalioma),
  • No history of: severe psychiatric disorder, alcohol or drug abuse, inflammatory bowel disease, microscopic colitis, diverticulitis or ileus, major abdominal surgery (except appendectomy, cholecystectomy, caesarean section, and hysterectomy)
  • No "red flags'' indicating severe undiagnosed disease: Night sweats (Repeated episodes of extreme perspiration that may soak nightclothes or bedding), Unintentional weight loss (≥ 4.5 kilograms, or 5% of normal body weight) over less than 6 months without knowing the reason, or blood in stool
  • Not pregnant
  • Ability to comply with protocol requirements

Exclusion

    Key Trial Info

    Start Date :

    December 1 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2033

    Estimated Enrollment :

    728 Patients enrolled

    Trial Details

    Trial ID

    NCT06117865

    Start Date

    December 1 2023

    End Date

    December 31 2033

    Last Update

    May 16 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Haukeland University Hospital

    Bergen, Vestlandet, Norway, 5021